Business Development for the Biotechnology and Pharmaceutical Industry
| Publication Date | May 2008 |
|---|---|
| Publisher | Ashgate Publishing |
| Product Type | Book |
| Pages | 202 |
| ISBN Number | 9780566087813 |
| Product Code | ASH00421 |
Summary
Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.
Content
- Foreword
- The role of business development
- Planning the portfolio
- Identifying the needs
- Profiling and searching for opportunities
- Modelling and valuation
- Structuring the value
- Due diligence and negotiations
- Sealing the deal - the contract
- Making the transaction work
- Glossary
- Index.
About this Product
Delivery Details
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Will Obama’s Victory Provide the US Green Energy Market with the Spur it Needs? >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Profound Effects on Car Industry when Europe’s Largest Economy Enters Recession >>
Business Books
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories














